EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)— 510(k) K241923

Substantially Equivalent

Ever Fortune.Ai, Co., Ltd.

FDA 510(k) clearance K241923 for EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100), Substantially Equivalent on 2024-12-06. Applicant: Ever Fortune.Ai, Co., Ltd..

Clearance details

Applicant
Ever Fortune.Ai, Co., Ltd.
Product code
Code QAS
Advisory panel
Radiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Taichung City, TW
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.